Onconetics Pharmaceuticals
Latest round
- Seed
Last raised
- Sep 2017
Total raised
- Undisclosed
Investors
- 2
About Onconetics Pharmaceuticals
Onconetics Pharmaceuticals, Inc.Onconetics Pharmaceuticals, Inc. specializes in creating targeted cancer therapies. Founded in 2016 in San Francisco, US, the company has undergone strategic developments to enhance its operational focus. Luke Gruenert serves as the CEO and founder of the company, marking his leadership with experience from previous ventures.Onconetics Pharmaceuticals, Inc. is committed to developing advanced cancer therapies that leverage innovative drug delivery mechanisms and formulation technologies. Their focus lies in precision medicine solutions aimed at improving treatment outcomes for patients with various forms of cancer.Onconetics Pharmaceuticals, Inc.Onconetics Pharmaceuticals, Inc. aims to launch new cancer therapy products by 2025, focusing on enhancing their drug formulations and expanding their pipeline. The company plans to enter new markets in North America and Europe, targeting regions with high cancer prevalence.
Who invested in Onconetics Pharmaceuticals
2 investors across 1 round
See all investors in Onconetics Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Sep 25, 2017
Amount
Undisclosed
Investors
Questions about Onconetics Pharmaceuticals
Who invested in Onconetics Pharmaceuticals?
Onconetics Pharmaceuticals has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Onconetics Pharmaceuticals raised?
Onconetics Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Onconetics Pharmaceuticals last raise money?
Onconetics Pharmaceuticals's most recent round on record is a Seed, in Sep 2017.
What does Onconetics Pharmaceuticals do?
Onconetics Pharmaceuticals, Inc.
Where is Onconetics Pharmaceuticals headquartered?
Onconetics Pharmaceuticals is headquartered in San Francisco, US.
Which VCs invest in companies like Onconetics Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Onconetics Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Onconetics Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.